These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9279189)

  • 1. Systematic review of prophylactic vs rescue surfactant.
    Morley CJ
    Arch Dis Child Fetal Neonatal Ed; 1997 Jul; 77(1):F70-4. PubMed ID: 9279189
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant treatment for premature babies--a review of clinical trials.
    Morley CJ
    Arch Dis Child; 1991 Apr; 66(4 Spec No):445-50. PubMed ID: 2025043
    [No Abstract]   [Full Text] [Related]  

  • 3. The CURPAP study: an international randomized controlled trial to evaluate the efficacy of combining prophylactic surfactant and early nasal continuous positive airway pressure in very preterm infants.
    Sandri F; Plavka R; Simeoni U;
    Neonatology; 2008; 94(1):60-2. PubMed ID: 18196932
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials of natural surfactant extract in respiratory distress syndrome.
    Mercier CE; Soll RF
    Clin Perinatol; 1993 Dec; 20(4):711-35. PubMed ID: 8131364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early nasal continuous positive airway pressure with or without prophylactic surfactant therapy in the premature infant with respiratory distress syndrome.
    Schimmel MS; Hammerman C
    Pediatr Radiol; 2000 Oct; 30(10):713-4. PubMed ID: 11075609
    [No Abstract]   [Full Text] [Related]  

  • 6. AARC (American Association for Respiratory Care) clinical practice guideline. Surfactant replacement therapy.
    Respir Care; 1994 Aug; 39(8):824-9. PubMed ID: 10146088
    [No Abstract]   [Full Text] [Related]  

  • 7. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. School-age follow-up of prophylactic versus rescue surfactant trial: pulmonary, neurodevelopmental, and educational outcomes.
    Sinkin RA; Kramer BM; Merzbach JL; Myers GJ; Brooks JG; Palumbo DR; Cox C; Kendig JW; Mercier CE; Phelps DL
    Pediatrics; 1998 May; 101(5):E11. PubMed ID: 9565444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant treatment in the ICU: alternative interpretations of existing evidence.
    Strohmaier W; Marraro G
    Paediatr Anaesth; 2006 Aug; 16(8):813-5. PubMed ID: 16884462
    [No Abstract]   [Full Text] [Related]  

  • 11. Early surfactant for respiratory distress syndrome in premature infants.
    Scopesi F; Parodi A; Natalizia AR; Sannia A; Ramenghi LA
    Acta Biomed; 2013; 84 Suppl 1():12-4. PubMed ID: 24049954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surfactant replacement--prevention and therapy in respiratory distress syndrome].
    Schimmel MS
    Harefuah; 1992 Apr; 122(7):431-3. PubMed ID: 1592303
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2000; (2):CD000510. PubMed ID: 10796379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
    Fernandes CJ; Horst DA; O'Donovan DJ
    J Perinatol; 2005 May; 25(5):361-2; author reply 363. PubMed ID: 15861205
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Rojas-Reyes MX; Morley CJ; Soll R
    Cochrane Database Syst Rev; 2012 Mar; (3):CD000510. PubMed ID: 22419276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lucinactant for the prevention of respiratory distress syndrome in premature infants.
    Jordan BK; Donn SM
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):115-21. PubMed ID: 23473590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.